One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Prostate cancer is not just a man’s concern � the use of PSA screening in transgender women
Farnoosh Nik-Ahd, Jennifer T. Anger, Matthew R. Cooperberg & Stephen J. FreedlandÂ
doi : 10.1038/s41585-023-00780-9
Volume 20 Issue 6, June 2023
VR, reconstructive urology and the future of surgery education
Mikołaj Frankiewicz, Malte W. Vetterlein, Marcin Matuszewski & Young Academic Urologists (YAU) Trauma and Reconstructive Urology Working Group
Artificial intelligence in academic writing: a paradigm-shifting technological advance
Roei Golan, Rohit Reddy, Akhil Muthigi & Ranjith RamasamyÂ
Uncovering a link between COVID-19 and renal cell carcinoma
Samuel A. Gold & Vitaly MargulisÂ
Sexual health and treatment-related sexual dysfunction in sexual and gender minorities with prostate cancer
Daniel R. Dickstein, Collin R. Edwards, Eric J. Lehrer, Elizabeth S. Tarras, Matthew Gallitto, John Sfakianos, Matthew D. Galsky, Richard Stock, Joshua D. Safer, B. R. Simon Rosser & Deborah C. MarshallÂ
doi : 10.1038/s41585-023-00778-3
Prostate cancer treatment has substantial effects on sexual health and function. Sexual function is a vital aspect of human health and a critical component of cancer survivorship, and understanding the potential effects of different treatment modalities on sexual health is crucial.
Inheritance of paternal lifestyles and exposures through sperm DNA methylation
Katherine W. Greeson, Krista M. S. Crow, R. Clayton Edenfield & Charles A. Easley IVÂ
doi : 10.1038/s41585-022-00708-9
Many different lifestyle factors and chemicals present in the environment are a threat to the reproductive tracts of humans. The potential for parental preconception exposure to alter gametes and for these alterations to be passed on to offspring and negatively affect embryo growth and development is of concern.
The future of patient-derived xenografts in prostate cancer research
Mitchell G. Lawrence, Renea A. Taylor, Georgia B. Cuffe, Lisa S. Ang, Ashlee K. Clark, David L. Goode, Laura H. Porter, Clémentine Le Magnen, Nora M. Navone, Jack A. Schalken, Yuzhuo Wang, Wytske M. van Weerden, Eva Corey, John T. Isaacs, Peter S. Nelson & Gail P. RisbridgerÂ
doi : 10.1038/s41585-022-00706-x
Patient-derived xenografts (PDXs) are generated by engrafting human tumours into mice. Serially transplantable PDXs are used to study tumour biology and test therapeutics, linking the laboratory to the clinic.
